Time Adjustment of Hydrocortisone Doses During Shift Work in Patients
                    with Adrenal Insufficiency

Tina Kienitz; Christian Strasburger; Ulf Elbelt; Katharina Lang; Knut Mai; Thomas Bobbert; Marcus Quinkler

doi:10.1055/a-2549-5784

Hormone and Metabolic Research, Table of Contents

Horm Metab Res 2025; 57(04): 236-241
DOI: 10.1055/a-2549-5784

Original Article: Endocrine Care

Time Adjustment of Hydrocortisone Doses During Shift Work in Patients with Adrenal Insufficiency

Tina Kienitz

¹Endocrinology, Endocrinology in Charlottenburg, Berlin, Germany

²Department of Endocrinology and Metabolism, Charité – Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany

,

Christian Strasburger

²Department of Endocrinology and Metabolism, Charité – Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany

,

Ulf Elbelt

³Section Endocrinology/Diabetology, Medical Clinic B, Universitätsklinikum Ruppin-Brandenburg, Medizinische Hochschule Brandenburg, Neuruppin, Germany

⁴Endocrinology, Endokrinologikum Berlin, Berlin, Germany

,

Katharina Lang

¹Endocrinology, Endocrinology in Charlottenburg, Berlin, Germany

,

Knut Mai

²Department of Endocrinology and Metabolism, Charité – Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany

⁵Department of Human Nutrition, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany

,

Thomas Bobbert

²Department of Endocrinology and Metabolism, Charité – Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany

⁵Department of Human Nutrition, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany

,

Marcus Quinkler

¹Endocrinology, Endocrinology in Charlottenburg, Berlin, Germany

› Author Affiliations

Abstract

Shift work causes a disruption between the circadian system and the external light-dark cycle, but also a misalignment between various levels of the circadian system. There is no information on patients with adrenal insufficiency (AI) who are working shifts. The objective of the study was to analyze the hormone replacement therapy with hydrocortisone (HC) and the adaptation scheme in patients with AI on shifts. Patients working on shifts (n=15) from two German endocrine centers received a questionnaire regarding their therapy scheme, dose adaptations, working shifts, dose adaptations during working shifts, and occurrence of adrenal crisis. We observed that 20% of patients stated that they experience difficulties taking glucocorticoid replacement on time, 40% of patients reported these difficulties to occur only occasionally. Consequently, nearly half of the patients had forgotten to take their replacement therapy at some point. More than 50% of patients reported an adrenal crisis during the last two years. The timely adaptation of HC or of modified-release HC during shifts was very inhomogeneous. In conclusion, the adaptation schemes for HC dosing during shift work are currently not evidence-based but opinion-driven. Our findings highlight the need for further investigations of shift workers with AI.

Keywords

hydrocortisone - Addison’s disease - circadian rhythm - secondary adrenal insufficiency - modified-release hydrocortisone

Full Text

References

References
1 Allolio B. Adrenal crisis. Eur J Endocrinol 2015; 172: R115-R124
2 Hahner S, Allolio B. Therapeutic management of adrenal insufficiency. Best Pract Res Clin Endocrinol Metab 2009; 23: 167-179
3 Hahner S, Ross RJ, Arlt W. et al. Adrenal insufficiency. Nat Rev Dis Primers 2021; 7: 19
4 Bancos I, Hahner S, Tomlinson J. et al. Diagnosis and management of adrenal insufficiency. Lancet Diabetes Endocrinol 2015; 3: 216-226
5 Bornstein SR, Allolio B, Arlt W. et al. Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2016; 101: 364-389
6 Quinkler M, Beuschlein F, Hahner S. et al. Nebennierenrinden-insuffizienz – Lebensbedrohliche erkrankung mit vielfältigen ursachen. Dtsch Arzteblatt Int 2013; 110: 882-888
7 Husebye ES, Allolio B, Arlt W. et al. Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. J Intern Med 2014; 275: 104-115
8 Oksnes M, Ross R, Løvås K. Optimal glucocorticoid replacement in adrenal insufficiency. Best Pract Res Clin Endocrinol Metab 2015; 29: 3-15
9 Paragliola RM, Corsello SM. Secondary adrenal insufficiency: from the physiopathology to the possible role of modified-release hydrocortisone treatment. Minerva Endocrinol 2018; 43: 183-197
10 Murray RD, Ekman B, Uddin S. et al. Management of glucocorticoid replacement in adrenal insufficiency shows notable heterogeneity – data from the EU-AIR. Clin Endocrinol (Oxf) 2017; 86: 340-346
11 Quinkler M, Nilsen RM, Zopf K. et al. Modified-release hydrocortisone decreases BMI and HbA1c in patients with primary and secondary adrenal insufficiency. Eur J Endocrinol 2015; 172: 619-626
12 Johannsson G, Bergthorsdottir R, Nilsson AG. et al. Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study. Eur J Endocrinol 2009; 161: 119-130
13 Nilsson AG, Bergthorsdottir R, Burman P. et al. Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency: a phase 3b, open-label, extension study. Eur J Endocrinol 2017; 176: 715-725
14 Guarnotta V, Stefano CDi, Tomasello L. et al. Conventional steroids vs. dual-release hydrocortisone on metabolic, cardiovascular, and bone outcomes in adrenal insufficiency: a 10-year study. Eur J Endocrinol 2024; 191: 300-311
15 Giordano R, Guaraldi F, Berardelli R. et al. Dual-release hydrocortisone in Addison’s disease – a review of the literature. Eur Endocrinol 2014; 10: 75-78
16 Dineen R, Martin-Grace J, Ahmed KMS. et al. Cardiometabolic and psychological effects of dual-release hydrocortisone: a cross-over study. Eur J Endocrinol 2021; 184: 253-265
17 Dineen RA, Martin-Grace J, Ahmed KMS. et al. Tissue glucocorticoid metabolism in adrenal insufficiency: a prospective study of dual-release hydrocortisone therapy. J Clin Endocrinol Metab 2023; 108: 3178-3189
18 Tucci L, Fanelli F, Improta I. et al. Monitoring adrenal insufficiency through salivary steroids: a pilot study. Eur J Endocrinol 2024; 190: 327-337
19 Veldhuis JD, Iranmanesh A, Lizarralde G. et al Downloaded from [Internet]. Am J Physiol Endocrinol Metab at Charité-Med. Bibliothek 1989; 257 Available from http://ajpendo.physiology.org/
20 Grossman A, Johannsson G, Quinkler M. et al. Perspectives on the management of adrenal insufficiency: clinical insights from across Europe. Eur J Endocrinol 2013; 169: R165-R175
21 Erichsen MM, Løvås K, Fougner KJ. et al. Normal overall mortality rate in Addison’s disease, but young patients are at risk of premature death. Eur J Endocrinol 2009; 160: 233-237
22 Sherlock M, Ayuk J, Tomlinson JW. et al. Mortality in patients with pituitary disease. Endocr Rev 2010; 31: 301-342
23 Skov J, Sundstrom A, Ludvigsson JF. et al. Sex-specific risk of cardiovascular disease in autoimmune Addison disease-a population-based cohort study. J Clin Endocrinol Metab 2019; 104: 2031-2040
24 Schulz J, Frey KR, Cooper MS. et al. Reduction in daily hydrocortisone dose improves bone health in primary adrenal insufficiency. Eur J Endocrinol 2016; 174: 531-538
25 Løvås K, Gjesdal CG, Christensen M. et al. Glucocorticoid replacement therapy and pharmacogenetics in Addison’s disease: effects on bone. Eur J Endocrinol 2009; 160: 993-1002
26 Hahner S, Spinnler C, Fassnacht M. et al. High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study. J Clin Endocrinol Metab 2015; 100: 407-416
27 Boivin DB, Boudreau P, Kosmadopoulos A. Disturbance of the circadian system in shift work and its health impact. J Biol Rhythms 2022; 37: 3-28
28 Fritschi L, Glass DC, Heyworth JS. et al. Hypotheses for mechanisms linking shiftwork and cancer. Med Hypotheses 2011; 77: 430-436
29 Szosland D. Shift work and metabolic syndrome, diabetes mellitus and ischaemic heart disease. Int J Occup Med Environ Health 2010; 23: 287-291
30 Hemmer A, Mareschal J, Dibner C. et al. The effects of shift work on cardio-metabolic diseases and eating patterns. Nutrients 2021; 13: 4178
31 Morris CJ, Aeschbach D, Scheer FAJL. Circadian system, sleep and endocrinology. Mol Cell Endocrinol 2012; 349: 91-104
32 Scheer FAJL, Hilton MF, Mantzoros CS. et al. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci U S A 2009; 106: 4453-4458
33 Oster H, Challet E, Ott V. et al. The functional and clinical significance of the 24-hour rhythm of circulating glucocorticoids. Endocr Rev 2017; 38: 3-45
34 Hennig J, Kieferdorf P, Moritz C. et al. Changes in cortisol secretion during shiftwork: implications for tolerance to shiftwork?. Ergonomics 1998; 41: 610-621
35 Touitou Y, Motohashi Y, Reinberg A. et al. Effect of shift work on the night-time secretory patterns of melatonin, prolactin, cortisol and testosterone. Eur J Appl Physiol Occup Physiol 1990; 60: 288-292
36 Weibel L, Spiegel K, Follenius M. et al. Internal dissociation of the circadian markers of the cortisol rhythm in night workers. Am J Physiol 1996; 270: E608-E613
37 Roden M, Koller M, Pirich K. et al. The circadian melatonin and cortisol secretion pattern in permanent night shift workers. Am J Physiol 1993; 265: R261-R267
38 Burger-Stritt S, Eff A, Quinkler M. et al. Standardised patient education in adrenal insufficiency: a prospective multi-centre evaluation. Eur J Endocrinol 2020; 183: 119-127
39 Mullins HM, Cortina JM, Drake CL. et al. Sleepiness at work: a review and framework of how the physiology of sleepiness impacts the workplace. J Appl Psychol 2014; 99: 1096-1112
40 Chapman SCE, Llahana S, Carroll P. et al. Glucocorticoid therapy for adrenal insufficiency: nonadherence, concerns and dissatisfaction with information. Clin Endocrinol (Oxf) 2016; 84: 664-671
41 Bostock F, Mortimore G. Considering the impact of shift working on health. Br J Nurs 2024; 33: 120-124
42 Akerstedt T. Shift work and disturbed sleep/wakefulness. Sleep Med Rev 1998; 2: 117-128
43 Ohayon MM, Lemoine P, Arnaud-Briant V. et al. Prevalence and consequences of sleep disorders in a shift worker population. J Psychosom Res 2002; 53: 577-583
44 Plat L, Leproult R, L’hermite-Baleriaux M. et al. Metabolic effects of short-term elevations of plasma cortisol are more pronounced in the evening than in the morning. J Clin Endocrinol Metab 1999; 84: 3082-3092
45 Darji M, Pannain S, Sam S. et al. THU611 circadian misalignment of melatonin secretion in adrenal insufficiency (AI). J Endocr Soc 2023; 7: bvad114.141

Supplementary Material